GILD Jun 2025 50.000 put

OPR - OPR Delayed Price. Currency in USD

Add to watchlist

0.3800

0.0000

(0.00%)

As of 09:30AM EDT. Market open.

Zacks
Gilead Sciences (GILD) Increases Yet Falls Behind Market: What Investors Need to Know
Gilead Sciences (GILD) reachead $85.21 at the closing of the latest trading day, reflecting a +0.92% change compared to its last close.
Business Wire
Gilead Presents Additional Efficacy, Safety and Demographic Data From PURPOSE 2 Trial at 5th HIV Research for Prevention Conference
FOSTER CITY, Calif., October 07, 2024--Gilead Sciences, Inc. (Nasdaq: GILD) today announced additional data from its pivotal Phase 3 PURPOSE 2 trial (NCT04925752) providing an overview of the efficacy and safety of twice-yearly lenacapavir, the company’s injectable HIV-1 capsid inhibitor, for the investigational use of HIV prevention among a broad and geographically diverse range of cisgender men and gender-diverse people.
Simply Wall St.
Gilead Sciences' (NASDAQ:GILD) investors will be pleased with their favorable 62% return over the last five years
When you buy and hold a stock for the long term, you definitely want it to provide a positive return. Furthermore...